✦ LIBER ✦

7130 Efficacy and safety of sorafenib in patients with advanced clear-cell renal-cell carcinoma (RCC) with bone metastases: results from the phase III target study

✍ Scribed by Bukowski, R.; Eisen, T.E.; Stadler, W.S.; Szczylik, C.S.; Oudard, O.S.; Siebels, M.S.; Negrier, S.N.; Anderson, S.A.; Shan, M.S.; Escudier, B.E.

Book ID: 122001108
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 48 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71463-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7132 Safety and efficacy of sorafenib in

7132 Safety and efficacy of sorafenib in patients with advanced renal cell carcinoma (RCC) with varying histologies: results from the phase 3, open access study of sorafenib in European patients with advanced RCC (EU-ARCCS)

✍ Bokemeyer, C.; Gore, M.; Bracarda, I.; Richel, N.; Staehler, D.; von der Maase, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

RANDOMISED PHASE III TRIAL OF THE MULTIK

RANDOMISED PHASE III TRIAL OF THE MULTIKINASE INHIBITOR SORAFENIB (BAY 43-9006) IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC)

✍ Escudier, B.; Szczylik, C.; Eisen, T.; Oudard, S.; Stadler, W.M.; Schwartz, B.; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

✍ S. Negrier; E. Jäger; C. Porta; D. McDermott; M. Moore; J. Bellmunt; S. Anderson 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 316 KB

794 ORAL Randomized Phase III trial of t

794 ORAL Randomized Phase III trial of the multi-kinase inhibitor sorafenib (BAY 43–9006) in patients with advanced renal cell carcinoma (RCC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

7106 Predictive and prognostic factors i

7106 Predictive and prognostic factors in a phase III study of pazopanib in patients with advanced renal cell carcinoma (RCC)

✍ Sternberg, C.; Davis, I.; Wagstaff, J.; Hawkins, R.; Chen, M.; Ding, J. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A LARGE OPEN-LABEL, NON-COMPARATIVE, PHA

A LARGE OPEN-LABEL, NON-COMPARATIVE, PHASE III STUDY OF THE MULTI-TARGETED KINASE INHIBITOR SORAFENIB IN EUROPEAN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

✍ J. Beck; E. Verzoni; S. Negrier; U. Keilholz; C. Szczylik; S. Bracarda; C. Bokem 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB